More Press Releases

View Older Stories View Newer Stories

Sep 9, 2024 08:00AM PodcastOne Names Steve Lehman Vice Chairman to Drive Its Mergers, Acquisitions and Strategy Efforts
Sep 9, 2024 08:00AM Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01
Sep 9, 2024 08:00AM Velcan Holdings: Share buyback program - weekly statement
Sep 9, 2024 08:00AM Technip Energies appoints new Managing Director for Americas
Sep 9, 2024 07:58AM Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
Sep 9, 2024 07:58AM Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024
Sep 9, 2024 07:55AM Fuerte Metals Intercepts 7.3 g/t AuEq over 2.5 m, 7.5 g/t AuEq over 1.5 m and 9.2 g/t AuEq over 0.9 m at its Cristina Project in Chihuahua, Mexico
Sep 9, 2024 07:55AM Koppers Management Meeting with Financial Community in Denver and Seattle
Sep 9, 2024 07:55AM RIGImmune Announces Multiple Oral Presentations for Intranasal RIG-101 at European Respiratory Society Congress 2024
Sep 9, 2024 07:55AM Scientist.com and Evotec Partner to Accelerate Drug Discovery and Development
Sep 9, 2024 07:50AM BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Sep 9, 2024 07:45AM Sphere 3D Corp. Signs Letter of Intent to Acquire a 12.5 MW Site in Iowa Featuring Average Sub -4c Energy, Set to be Operational by December 2024
Sep 9, 2024 07:46AM China’s Private “Starlink” Achieves Nearly Half Deployment, Launches Global Commercial Services
Sep 9, 2024 07:45AM Latigo Biotherapeutics Appoints Tim Lugo as Chief Financial Officer and Adds Beth Seidenberg and Jim Tananbaum to Board of Directors
Sep 9, 2024 07:45AM Intuitive Machines Announces Key Leadership Appointments
Sep 9, 2024 07:45AM Kvika banki hf.: Transaction in relation to a share buyback programme
Sep 9, 2024 07:43AM Sirsram Medical announces NMPA approval for DAXXIFY®
Sep 9, 2024 07:42AM Jumptuit Introduces Global Sensory Intelligence (GSI) to Reduce Geopolitical and Environmental Event Risk
Sep 9, 2024 07:41AM Alliance Trust PLC - Net Asset Value
Sep 9, 2024 07:35AM 4M Therapeutics Announces Positive Preclinical Data for Lead Asset 4MT2001 Demonstrating Central Nervous System Target Engagement
Sep 9, 2024 07:34AM Protein Candy™ Launches the World's First "Super Candy"
Sep 9, 2024 07:30AM NewStream Energy Technologies Group Provides Business Update
Sep 9, 2024 07:30AM Atlas Salt Enters Strategic MOU with Sandvik Mining and Rock Solutions for Underground Mobile Equipment Supply, Including $73 Million Financing
Sep 8, 2024 06:20PM Ondas Receives $8.0 Million Purchase Order for Iron Drone Raider Systems from Major Military Customer for Aerial Protection Against Hostile Drones
Sep 9, 2024 07:32AM Medicenna Presents Preclinical Results from its IL-2 Super-Antagonist and Anti-PD1-IL-2 BiSKIT Programs at The Promise of Interleukin-2 Therapy Conference
Sep 9, 2024 07:32AM PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
Sep 9, 2024 07:30AM Cuprite LLC Acquires Ground Adjacent and Internal to StrikePoint Gold's Cuprite Gold Project, Walker Lane, Nevada
Sep 9, 2024 07:00AM Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada
Sep 9, 2024 07:30AM Myriad Uranium Reports on Recent Ground Magnetometer Survey at the Copper Mountain Uranium Project, Wyoming
Sep 9, 2024 07:00AM Gold Terra Announces a 2 Year Extension on Option Agreement with Newmont to November 21st, 2027 to purchase 100% of Past Producing 16 g/t Gold Con Mine, Yellowknife, NWT
Sep 9, 2024 07:30AM CEO.CA's Inside the Boardroom: Altamira Discovers New Porphyry Outcrops 1.6km East of Maria Bonita
Sep 9, 2024 07:30AM Thunder Gold Closes $1 Million Non-Brokered Private Placement
Sep 9, 2024 07:31AM Viasat Announces Proposed Private Placement of $1,250 Million of Senior Secured Notes
Sep 9, 2024 07:31AM Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
Sep 9, 2024 07:31AM Progress Software to Report Third Quarter 2024 Financial Results on September 24, 2024
Sep 9, 2024 07:30AM TGS: MANDATORY NOTIFICATION OF TRADES
Sep 9, 2024 07:30AM Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of the Bank of America Securities 2024 Global Real Estate Conference
Sep 9, 2024 07:30AM Record date is determined for South Bow spinoff
Sep 9, 2024 07:30AM Itafos Announces Amendment and Extension of Its Existing Credit Facilities
Sep 9, 2024 07:30AM G Mining Ventures to Acquire the CentroGold Project from BHP
Sep 9, 2024 07:30AM Revival Gold Reports Positive Metallurgical Tests Results at Mercur
Sep 9, 2024 07:30AM First Trust Introduces a Small and Mid Cap Dividend Achievers ETF
Sep 9, 2024 07:30AM Cytokinetics Announces Data From Phase 1 Study of CK-4021586
Sep 9, 2024 07:30AM Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
Sep 9, 2024 07:30AM Recognize Announces Majority Investment in Managed Services Leader Blue Mantis
Sep 9, 2024 07:30AM ALLIED GOLD TO COMMENCE TRADING ON OTCQX EXCHANGE
Sep 9, 2024 07:30AM Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite's Cell Therapy Flagship Program
Sep 9, 2024 07:30AM First Citizens Bank Serves as Co-Lead Arranger on $300 Million Credit Facility for Swift Current Energy
Sep 9, 2024 07:30AM Titan Announces Q&A Session with Shareholders
Sep 9, 2024 07:30AM Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
View Newer Stories View Older Stories